SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection

(Institute for Basic Science) SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection. The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19 infection.

https://www.eurekalert.org/pub_releases/2021-07/ifbs-srt063021.php

Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

More News: COVID-19 | Infectious Diseases | SARS | Science | Vaccines